{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T08:30:20Z","timestamp":1790670620824,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T00:00:00Z","timestamp":1568419200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T00:00:00Z","timestamp":1568419200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004320","name":"Shiraz University of Medical Sciences","doi-asserted-by":"publisher","award":["98-01-42-20527"],"award-info":[{"award-number":["98-01-42-20527"]}],"id":[{"id":"10.13039\/501100004320","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>After years of efforts on the control of malaria, it remains as a most deadly infectious disease. A major problem for the available anti-malarial drugs is the occurrence of drug resistance in <jats:italic>Plasmodium<\/jats:italic>. Developing of new compounds or modification of existing anti-malarial drugs is an effective approach to face this challenge. Quantitative structure activity relationship (QSAR) modelling plays an important role in design and modification of anti-malarial compounds by estimation of the activity of the compounds.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this research, the QSAR study was done on anti-malarial activity of 33 imidazolopiperazine compounds based on artificial neural networks (ANN). The structural descriptors of imidazolopiperazine molecules was used as the independents variables and their activity against 3D7 and W2 strains was used as the dependent variables. During modelling process, 70% of compound was used as the training and two 15% of imidazolopiperazines were used as the validation and external test sets. In this work, stepwise multiple linear regression was applied as the valuable selection and ANN with Levenberg\u2013Marquardt algorithm was utilized as an efficient non-linear approach to correlate between structural information of molecules and their anti-malarial activity.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The sufficiency of the suggested method to estimate the anti-malarial activity of imidazolopiperazine compounds at two 3D7 and W2 strains was demonstrated using statistical parameters, such as correlation coefficient (R<jats:sup>2<\/jats:sup>), mean square error (MSE). For instance R<jats:sup>2<\/jats:sup><jats:sub>train<\/jats:sub>\u2009=\u20090.947, R<jats:sup>2<\/jats:sup><jats:sub>val<\/jats:sub>\u2009=\u20090.959, R<jats:sup>2<\/jats:sup><jats:sub>test<\/jats:sub>\u2009=\u20090.920 shows the potential of the suggested model for the prediction of 3D7 activity. Different statistical approaches such as and applicability domain (AD) and y-scrambling was also showed the validity of models.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>QSAR can be an efficient way to virtual screening the molecules to design more efficient compounds with activity against malaria (3D7 and W2 strains). Imidazolopiperazines can be good candidates and change in the structure and functional groups can be done intelligently using QSAR approach to rich more efficient compounds with decreasing trial\u2013error runs during synthesis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12936-019-2941-5","type":"journal-article","created":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T04:23:57Z","timestamp":1568435037000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Quantitative structure\u2013activity relationship to predict the anti-malarial activity in a set of new imidazolopiperazines based on artificial neural networks"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5940-1229","authenticated-orcid":false,"given":"Saeed","family":"Yousefinejad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjan","family":"Mahboubifar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rayhaneh","family":"Eskandari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,14]]},"reference":[{"key":"2941_CR1","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.ejmech.2016.11.025","volume":"125","author":"M Mishra","year":"2017","unstructured":"Mishra M, Mishra VK, Kashaw V, Iyer AK, Kashaw SK. Comprehensive review on various strategies for antimalarial drug discovery. Eur J Med Chem. 2017;125:1300\u201320.","journal-title":"Eur J Med Chem"},{"key":"2941_CR2","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1016\/j.bmcl.2013.03.067","volume":"23","author":"MA Biamonte","year":"2013","unstructured":"Biamonte MA, Wanner J, Le Roch KG. Recent advances in malaria drug discovery. Bioorg Med Chem Lett. 2013;23:2829\u201343.","journal-title":"Bioorg Med Chem Lett"},{"key":"2941_CR3","unstructured":"Marson BM, Vilhena R de O, Fachi MM, Pontes FLD, de Almeida BMM, Pontarolo R. Challenges and perspectives in malaria treatment. In: Malaria. Avid Science Publ; 2019. \n                    http:\/\/www.avidscience.com\/book\/malaria\/\n                    \n                  ."},{"key":"2941_CR4","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/nrmicro3138","volume":"11","author":"EL Flannery","year":"2013","unstructured":"Flannery EL, Chatterjee AK, Winzeler EA. Antimalarial drug discovery\u2014approaches and progress towards new medicines. Nat Rev Microbiol. 2013;11:849\u201362.","journal-title":"Nat Rev Microbiol"},{"key":"2941_CR5","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/B978-0-444-62652-3.00003-X","volume":"52","author":"F Calder\u00f3n","year":"2013","unstructured":"Calder\u00f3n F, Wilson DM, Gamo F-J. Antimalarial drug discovery: recent progress and future directions. Prog Med Chem. 2013;52:97\u2013151.","journal-title":"Prog Med Chem"},{"key":"2941_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/sj.bjp.0707306","volume":"152","author":"S Ekins","year":"2007","unstructured":"Ekins S, Mestres J, Testa B. In silico pharmacology for drug discovery: applications to targets and beyond. Br J Pharmacol. 2007;152:21\u201337.","journal-title":"Br J Pharmacol"},{"key":"2941_CR7","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2174\/1386207318666141229125527","volume":"18","author":"P Kumar Ojha","year":"2015","unstructured":"Kumar Ojha P, Roy K. The current status of antimalarial drug research with special reference to application of QSAR models. Comb Chem High Throughput Screen. 2015;18:91\u2013128.","journal-title":"Comb Chem High Throughput Screen."},{"key":"2941_CR8","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.1016\/S0968-0896(01)00241-3","volume":"9","author":"VK Agrawal","year":"2001","unstructured":"Agrawal VK, Srivastava R, Khadikar PV. QSAR Studies on some antimalarial sulfonamides. Bioorg Med Chem. 2001;9:3287\u201393.","journal-title":"Bioorg Med Chem"},{"key":"2941_CR9","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.1016\/S0968-0896(02)00161-X","volume":"10","author":"F Cheng","year":"2002","unstructured":"Cheng F, Shen J, Luo X, Zhu W, Gu J, Ji R, et al. Molecular docking and 3-D-QSAR studies on the possible antimalarial mechanism of artemisinin analogues. Bioorg Med Chem. 2002;10:2883\u201391.","journal-title":"Bioorg Med Chem"},{"key":"2941_CR10","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1016\/j.bmc.2005.11.015","volume":"14","author":"AR Katritzky","year":"2006","unstructured":"Katritzky AR, Kulshyn OV, Stoyanova-Slavova I, Dobchev DA, Kuanar M, Fara DC, et al. Antimalarial activity: a QSAR modeling using CODESSA PRO software. Bioorg Med Chem. 2006;14:2333\u201357.","journal-title":"Bioorg Med Chem"},{"key":"2941_CR11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00894-007-0249-9","volume":"14","author":"FJB Cardoso","year":"2008","unstructured":"Cardoso FJB, de Figueiredo AF, da Silva Lobato M, de Miranda RM, de Almeida RCO, Pinheiro JC. A study on antimalarial artemisinin derivatives using MEP maps and multivariate QSAR. J Mol Model. 2008;14:39\u201348.","journal-title":"J Mol Model"},{"key":"2941_CR12","doi-asserted-by":"publisher","first-page":"159","DOI":"10.5897\/AJPP2018.4904","volume":"12","author":"A Cheoymang","year":"2018","unstructured":"Cheoymang A, Na-Bangchang K. A systematic review: application of in silico models for antimalarial drug discovery. Afr J Pharm Pharmacol. 2018;12:159\u201367.","journal-title":"Afr J Pharm Pharmacol."},{"key":"2941_CR13","doi-asserted-by":"publisher","first-page":"6437","DOI":"10.1128\/AAC.03478-14","volume":"58","author":"FJ Leong","year":"2014","unstructured":"Leong FJ, Zhao R, Zeng S, Magnusson B, Diagana TT, Pertel P. A first-in-human randomized, double-blind, placebo-controlled, single- and multiple-ascending oral dose study of novel imidazolopiperazine KAF156 to assess its safety, tolerability, and pharmacokinetics in healthy adult volunteers. Antimicrob Agents Chemother. 2014;58:6437\u201343.","journal-title":"Antimicrob Agents Chemother"},{"key":"2941_CR14","first-page":"4","volume":"47","author":"PY Chia","year":"2018","unstructured":"Chia PY, Hsu LY, Yeo TW. Malaria in 2018: looking to the past and moving into the future. Ann Acad Med. 2018;47:4.","journal-title":"Ann Acad Med."},{"key":"2941_CR15","doi-asserted-by":"publisher","first-page":"4244","DOI":"10.1021\/jm300041e","volume":"55","author":"A Nagle","year":"2012","unstructured":"Nagle A, Wu T, Kuhen K, Gagaring K, Borboa R, Francek C, et al. Imidazolopiperazines: lead optimization of the second-generation antimalarial agents. J Med Chem. 2012;55:4244\u201373.","journal-title":"J Med Chem"},{"key":"2941_CR16","doi-asserted-by":"publisher","first-page":"5116","DOI":"10.1021\/jm2003359","volume":"54","author":"T Wu","year":"2011","unstructured":"Wu T, Nagle A, Kuhen K, Gagaring K, Borboa R, Francek C, et al. Imidazolopiperazines: hit to lead optimization of new antimalarial agents. J Med Chem. 2011;54:5116\u201330.","journal-title":"J Med Chem"},{"key":"2941_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/9783527628766","volume-title":"Molecular descriptors for chemoinformatics","author":"R Todeschini","year":"2009","unstructured":"Todeschini R, Consonni V. Molecular descriptors for chemoinformatics. 2nd ed. Weinheim: WILEY-VCH; 2009.","edition":"2"},{"key":"2941_CR18","first-page":"237","volume":"56","author":"A Mauri","year":"2006","unstructured":"Mauri A, Consonni V, Pavan M, Todeschini R. Dragon software: an easy approach to molecular descriptor calculations. MATCH Commun Math Comput Chem. 2006;56:237\u201348.","journal-title":"MATCH Commun Math Comput Chem."},{"key":"2941_CR19","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.chemolab.2015.06.016","volume":"149","author":"S Yousefinejad","year":"2015","unstructured":"Yousefinejad S, Hemmateenejad B. Chemometrics tools in QSAR\/QSPR studies: a historical perspective. Chemom Intell Lab Syst. 2015;149:177\u2013204.","journal-title":"Chemom Intell Lab Syst"},{"key":"2941_CR20","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s11224-018-1242-x","volume":"30","author":"S Yousefinejad","year":"2019","unstructured":"Yousefinejad S, Mahboubifar M, Rasekh S. Prediction of different antibacterial activity in a new set of formyl hydroxyamino derivatives with potent action on peptide deformylase using structural information. Struct Chem. 2019;30:925\u201336.","journal-title":"Struct Chem"},{"key":"2941_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1021\/ci0342472","volume":"44","author":"DM Hawkins","year":"2004","unstructured":"Hawkins DM. The problem of overfitting. J Chem Inf Comput Sci. 2004;44:1\u201312.","journal-title":"J Chem Inf Comput Sci"},{"key":"2941_CR22","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/minf.201400030","volume":"33","author":"P Gramatica","year":"2014","unstructured":"Gramatica P. External evaluation of QSAR models, in addition to cross-validation: verification of predictive capability on totally new chemicals. Mol Inform. 2014;33:311\u20134.","journal-title":"Mol Inform."},{"key":"2941_CR23","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1177\/026119290503300209","volume":"33","author":"TI Netzeva","year":"2005","unstructured":"Netzeva TI, Worth AP, Aldenberg T, Benigni R, Cronin MD, Gramatica P, et al. Current status of methods for defining the applicability domain of (quantitative) structure\u2013activity relationships. Altern Lab Anim. 2005;33:155\u201373.","journal-title":"Altern Lab Anim"},{"key":"2941_CR24","doi-asserted-by":"publisher","first-page":"4791","DOI":"10.3390\/molecules17054791","volume":"17","author":"F Sahigara","year":"2012","unstructured":"Sahigara F, Mansouri K, Ballabio D, Mauri A, Consonni V, Todeschini R. Comparison of different approaches to define the applicability domain of QSAR models. Molecules. 2012;17:4791\u2013810.","journal-title":"Molecules"},{"key":"2941_CR25","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/qsar.200610151","volume":"26","author":"P Gramatica","year":"2007","unstructured":"Gramatica P. Principles of QSAR models validation: internal and external. QSAR Comb Sci. 2007;26:694\u2013701.","journal-title":"QSAR Comb Sci"},{"key":"2941_CR26","doi-asserted-by":"publisher","first-page":"42266","DOI":"10.1039\/C5RA05930E","volume":"5","author":"S Yousefinejad","year":"2015","unstructured":"Yousefinejad S, Honarasa F, Montaseri H. Linear solvent structure-polymer solubility and solvation energy relationships to study conductive polymer\/carbon nanotube composite solutions. RSC Adv. 2015;5:42266\u201375.","journal-title":"RSC Adv."},{"key":"2941_CR27","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1021\/ci0500381","volume":"45","author":"S Dimitrov","year":"2005","unstructured":"Dimitrov S, Dimitrova G, Pavlov T, Dimitrova N, Patlewicz G, Niemela J, et al. A stepwise approach for defining the applicability domain of SAR and QSAR models. J Chem Inf Model. 2005;45:839\u201349.","journal-title":"J Chem Inf Model"},{"key":"2941_CR28","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.molliq.2015.08.055","volume":"212","author":"F Honarasa","year":"2015","unstructured":"Honarasa F, Yousefinejad S, Nasr S, Nekoeina M. Structure\u2013electrochemistry relationship in non-aqueous solutions: predicting the reduction potential of anthraquinones derivatives in some organic solvents. J Mol Liq. 2015;212:52\u20137.","journal-title":"J Mol Liq"},{"key":"2941_CR29","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.molliq.2017.06.081","volume":"241","author":"S Yousefinejad","year":"2017","unstructured":"Yousefinejad S, Eftekhari R, Honarasa F, Zamanian Z, Sedaghati F. Comparison between the gas\u2013liquid solubility of methanol and ethanol in different organic phases using structural properties of solvents. J Mol Liq. 2017;241:861\u20139.","journal-title":"J Mol Liq"},{"key":"2941_CR30","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1021\/ci010291a","volume":"41","author":"A Yasri","year":"2001","unstructured":"Yasri A, Hartsough D. Toward an optimal procedure for variable selection and QSAR model building. J Chem Inf Comput Sci. 2001;41:1218\u201327.","journal-title":"J Chem Inf Comput Sci"},{"key":"2941_CR31","first-page":"9","volume":"4","author":"W Yoo","year":"2014","unstructured":"Yoo W, Mayberry R, Bae S, Singh K, He QP, Lillard JW Jr. A study of effects of multicollinearity in the multivariable analysis. Int J Appl Sci Technol. 2014;4:9.","journal-title":"Int J Appl Sci Technol."},{"key":"2941_CR32","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/wics.84","volume":"2","author":"A Alin","year":"2010","unstructured":"Alin A. Multicollinearity. Wiley Interdiscip Rev Comput Stat. 2010;2:370\u20134.","journal-title":"Wiley Interdiscip Rev Comput Stat."}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-019-2941-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12936-019-2941-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-019-2941-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T09:19:35Z","timestamp":1600075175000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-019-2941-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,14]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2941"],"URL":"https:\/\/doi.org\/10.1186\/s12936-019-2941-5","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,14]]},"assertion":[{"value":"30 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article does not contain any studies involving human participants or clinical trial to require their consent for publication. Thus no ethical limitation was involved. The references of all data used in this research were also noted in the manuscript completely.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"310"}}